Association of a single nucleotide polymorphism in the matrix metalloproteinase-1 promoter with glioblastoma

International Journal of Cancer

Volumn 117, Issue 5, 2005, Pages 781-785

  McCready, Jessica ^a   Broaddus, William C ^a   Sykes, Virginia ^a   Fillmore, Helen L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumors; Matrix metalloproteinases; SNP; Transcriptional regulation

Indexed keywords

GENOMIC DNA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR ETS;

ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; ENZYME ASSAY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; TUMOR CELL CULTURE;

BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 26444488422     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21207     Document Type: Article

References (34)

1. CBTRUS. Statistical report: primary brain tumors in the United States, 1995-1999. 2002.
2. Behin A, Hoang-Xuan K, Carpentier AF, Delattre J-Y. Primary brain tumours in adults. Lancet 2003;361:323-31.
3. McCawley L, Matrisian L. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opinion Cell Biol 2001;13:534-40.
4. Egeblad M, Werb Z. New Functions for the Matrix Metalloproteinases in Cancer Progression. Nature Reviews: Cancer 2002;2:161-74.
5. Somerville RP, Oblander SA, Apte SA. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003;4:216.
6. Fillmore HL, Van Meter T, Broaddus WC. Membrane type metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neuro-Oncol 2001;53:187-202.
7. Van Meter T, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neuro-Oncol 2001;53:213-35.
8. Rao J, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta L, Sawaya R. Role of plasminogen activator and of 92-Kda type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neuro-Oncol 1994;18:129-38.
9. Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP, Pilkington GJ. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immuno-histochemistry and zymography in human primary brain tumors. International J Oncol 1998;13:153-7.
10. Rutka JT, Matsuzawa K, Hubbard SL, Fukuyama K, Becker L, Stetler-Stevenson WG, Edwards D, Dirks PB. Expression of TIMP-1, TIMP-2, 72-and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with invasiveness. Int J Oncol 1995;6:877-84.
11. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao J. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 1996:14:35-42.
12. Rao J. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev: Cancer 2003;3:489-501.
13. Nabeshima K, Inoue T, Shimao Y, Sameshima T. Matrix Metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 2002;52:255-64.
14. Binder D, Berger M. Proteases and the biology of glioma invasion. J Neuro-Oncol 2002;56:149-58.
15. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. Matrix Metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 1995;83:298-307.
16. Nakagawa T, Kubota T, Kabuto Masanori, Sato K, Kawano H, Hayakawa T, Okada Y. Production of matrix metallooproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994;81:69-77.
17. Rutter J, Mitchell T, Buttice G, Meyers J, Gusella J, Ozelius L, Brinckerhoff CE. A Single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5.
18. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-7.
19. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001;7:2344-6.
20. Zhu Y, Spitz M, Lei L, Mills G, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61:7825-9.
21. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoka Y. A Single Nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer. 2003;106:372-4.
22. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991;19:2499.
23. Ye S, Dhillon S, Turner S, Bateman A, Theaker J, Pickering R, Day I, Howell M. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 2001;61:1296-8.
24. Ghilardi G, Biondi ML, Carlson L, Leviti S, DeMonti M, Guagnellini E, Scorza R. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 2002;8:3820-3.
25. Wenham R, Calingarty Brian, Ali S, McClean K, Whitaker R, Bentley R, Lancaster J, Schildkraut J, Marks J, Berchuck A. Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J Soc Gynecol Investig 2003;10:381-7.
26. Sternlicht M, Werb Z. How matrix metalloproteinases regulate cell behavior, annual reviews in cell and developmental biology. 2001;17:463-516.
27. Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R. A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 2003;200:29-55.
28. Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 2004;33:323-6.
29. Przybylowska K, Zielinska J, Zadrozny M, Krawczyk T, Wozniak P, Rykala J, Kolacinska A, Morawiec Z, Drzewoski J, Blasiak J. An association between the matrix metalloproteinase 1 promoter gene polymoprhism and lymphnode metastasis in breast cancer. J Exp Clin Cancer Res 2004;23:121-5.
30. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T, Kudo R. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 2000;91:612-5.
31. Sun Y, Sun Y, Wenger L, Rutter J, Brinckerhoff CE, Cheung H. p53 Down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. The J Biol Chem 1999;274:11535-40.
32. Sun Y, Sun Y, Wenger L, Rutter J, Brinckerhoff CE, Cheung H. Human Metalloproteinase-1 (Collagenase-1) Is a Tumor Suppressor Protein P53 Target Gene. Ann N Y Acad Sci 1999;878:638-41.
33. Sun Y, Zeng XR, Wenger L, Firestein GS, Cheung HS. p53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex. J Cell Biochem 2004;92:258-69.
34. Brinckerhoff CE, Rutter J, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-30.